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Abstract
Background: The broad heterogeneity of antigen-antibody interactions brings tremendous challenges to the
design of a widely applicable learning algorithm to identify conformational B-cell epitopes. Besides the intrinsic
heterogeneity introduced by diverse species, extra heterogeneity can also be introduced by various data sources,
adding another layer of complexity and further confounding the research.
Results: This work proposed a staged heterogeneity learning method, which learns both characteristics and
heterogeneity of data in a phased manner. The method was applied to identify antigenic residues of heterogenous
conformational B-cell epitopes based on antigen sequences. In the first stage, the model learns the general epitope
patterns of each kind of propensity from a large data set containing computationally defined epitopes. In the second
stage, the model learns the heterogenous complementarity of these propensities from a relatively small guided data
set containing experimentally determined epitopes. Moreover, we designed an algorithm to cluster the predicted
individual antigenic residues into conformational B-cell epitopes so as to provide strong potential for real-world
applications, such as vaccine development. With heterogeneity well learnt, the transferability of the prediction model
was remarkably improved to handle new data with a high level of heterogeneity. The model has been tested on two
data sets with experimentally determined epitopes, and on a data set with computationally defined epitopes. This
proposed sequence-based method achieved outstanding performance - about twice that of existing methods,
including the sequence-based predictor CBTOPE and three other structure-based predictors.
Conclusions: The proposed method uses only antigen sequence information, and thus has much broader
applications.
Keywords: Staged heterogeneity learning, Conformational epitope, B-cell epitope, Epitope prediction,
Sequence-based
*Correspondence: jinyan.li@uts.edu.au
6Advanced Analytics Institute and Centre for Health Technologies, Faculty of
Engineering and Information Technology, University of Technology Sydney,
NSW 2007 Ultimo, Australia
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
The Author(s) BMCGenomics 2017, 18(Suppl 2):113 Page 2 of 13
Background
B-cell immunity provides a natural barrier for a host to
block the invasion of pathogens into cells. A vital medium
of this mechanism is the B-cell epitope, a small surface
area of an antigen that can be recognized and bound by
an antibody. The majority (more than 90%) of B-cell epi-
topes are conformational epitopes which are compact in
3D space but not continuous in sequence [1]. B-cell epi-
topes are able to stimulate B-cells to produce neutralizing
antibodies, and can be used to design safe vaccines, espe-
cially for vulnerable populations such as infants, young
children and the elderly, to be immunized against infec-
tious diseases [2]. Their accurate prediction is thus of
great significance, however, inhibited by several unsolved
issues. One serious issue is the broad heterogeneity of
epitope data.
Intrinsic heterogeneity exists in antigen-antibody inter-
actions due to long time evolution and frequent mutation
of pathogens, resulting in much non-trivial variance in
binding shapes and amino acid propensities. For exam-
ple, antibody Fab C179 binds to a concave region of the
H2 hemagglutinin, through a paratope mainly composed
of loops of the heavy and light chains (Fig. 1a). Differ-
ently, antibody C05 binds to a protrusive region of the
H3 hemagglutinin via a sheet segment of its heavy chain
(Fig. 1b). A more complicated example is the antibody
CR8043, which binds to a protrusive region of the H3
hemagglutinin by using segments of several sheets in the
heavy chain together with loops in the light chain (Fig. 1c).
Technique-induced heterogeneity adds another layer of
complexity. In fact, assay difference has a strong influence
on the annotation of conformational epitopes. Figure 1
(d–e) illustrates the heterogeneity introduced by wet-lab
experiments. In (d) and (e), the epitopes determined by
crystallography technologies (represented by the red and
magenta spheres) usually cover all the antigenic residues
bound by a specific antibody. Though the epitopes deter-
mined by an ELISA assay (the orange and yellow spheres)
or a biological activity assay (colored in blue) could some-
times be only parts of a conformational epitope, these
residues are functionally important and are likely to play a
vital role in antigen-antibody binding activity.
Such high levels of heterogeneity in B-cell epitope data
sets brings huge challenges for data mining algorithms
when attempting to make accurate predictions of the
vast number of unknown epitopes. Some previous stud-
ies have even yielded conflicting conclusions partially due
to insufficient understanding of this highly complex issue.
For example, Thornton et al. claimed that continuous
epitopes are usually located in protruding regions of pro-
teins [3]. This hypothesis was supported by [4], and the
protrusion index was followed to identify conformational
epitopes. Conversely, Kringelum et al. conjectured that
epitopes should be located in flatten areas, based on their
analysis of 107 antigen-antibody bound structures [5].
Hydrophilicity is another widely applied propensity in epi-
tope prediction. In [6], it was confirmed on 92 unbound
structures that hydrophilic residues can occur signifi-
cantly more frequently in epitopes than in other surface
areas, while hydrophobic residues can be depleted. Yet,
Kringelum et al. found that there is no significant devia-
tion in amino acid preference between epitopes and non-
epitope antigen surfaces [5]. Brief consideration of the
heterogeneity issue has come to the fore recently. Qi et al.
took the immune host information into account and con-
structed a prediction server, SEPPA 2.0 [7]. We performed
propensity analyses on several major antigen types (e.g.,
virus and bacterial) [6]. As these methods were based on
the knowledge of species, their training and analyses were
limited by data scale; for minority species, under-fitting is
a difficult issue for them to deal with.
Most of the current well-performing prediction meth-
ods are structure-based methods [1, 4, 7–15]. They
often use structural information like ASA [8], pro-
trusion index [4], contact number [1] and secondary
structure [13] to achieve a higher prediction accuracy.
However, a major drawback of structure-basedmethods is
the relatively small number of available protein structures.
It severely limits their application scope. In PDB (Protein
Data Bank), only 115764 biological macromolecular struc-
tures were released between 1976 and 4 Feb 2016, some of
which are of poor quality (e.g., low resolution). However,
a much larger number of antigen sequences have been or
can be translated from DNA sequences with ease. Thus,
sequence-based prediction methods, if they can match
or enhance the performance of structure-based methods,
will greatly improve prediction methodologies.
CBTOPE was the first comprehensive method pro-
posed to predict conformational B-cell epitopes from
antigen sequences [16]. Subsequent studies used differ-
ent combinations of sequence-derived propensities (like
amino acid scales and evolutionary propensity) through
various data mining methods, including: a weighted lin-
ear function [17], a re-sampling and propensity voting
method [18], an SVM model BEEPro [19], and a cost-
sensitive ensemble learning method CBEP [20]. These
methods handled neither the heterogeneity issue nor the
heterogeneity-induced inconsistency in the data well. In
most cases, homologous data sets or a single data set was
used to train their models, only capturing general epitope
patterns. For example, CBTOPE was trained on an in-
house data set extracted from IEDB [16], and [18] used a
bound-structure data set and an unbound data set to train
two separate models. These methods are likely to have
reduced performance on heterologous data sets.
In this paper, we design a new model for Sequence-
based conformational B-cell epitope Prediction (SePre).
To address the issue of data heterogeneity, a staged
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Fig. 1 Diversity of B-cell epitopes. (a) H2-C179, (b) H3-C05, (c) H3-CR8043, (d) A/Viet Nam/1203/2004(H5N1), (e) A/X-31(H3N2) a–c show diversified
antigen-antibody interactions. Antigens are shown in surface, and antibodies are shown in cartoon (heavy chain: wheat color, light chain: light blue).
d and e illustrate the diversity induced by assay types. The epitopes determined by crystallography are colored in red andmagenta, the epitopes
determined by ELISA are colored in orange and yellow, and the epitopes determined by biological activity are colored in blue
heterogeneity learning method is proposed to identify
antigenic residues. In the first stage, four sub-classifiers
are constructed using four types of propensity separately.
The aim is to learn the epitope patterns of each type
of propensity. To identify the intrinsic epitope patterns
from the diversified data is a nontrivial task, and there-
fore requires a large set of training data. In this work,
antigen sequences of 190 bound structures with computa-
tionally defined epitopes were used. In the second stage,
a decision tree model is trained using antigen sequences
with diversified experimentally determined epitopes. The
aim is to learn the heterogenous complementarity of the
propensities to form the basis of antibody-antigen inter-
actions. This is a relative simple process and could be
achieved on less guided data. It has the potential to act as
a fine tuning tool for minority class prediction. Furnished
with the well-learnt heterogeneity, the transferability of
this prediction model is remarkably improved to properly
handle heterogeneous test data. In addition, a clustering
algorithm is also developed to group nearby individual
antigenic residues for the recommendation of conforma-
tional epitopes.
Our prediction model has demonstrated outstanding
performance on two data sets containing experimen-
tally determined epitopes, and on an unbound data set
containing computationally defined epitopes. Compared
to the best performances of the sequence-based predic-
tor CBTOPE, and three other structure-based predictors,
DiscoTope 2.0, ElliPro and SEPPA 2.0, our method per-
formed around twice as well.
The proposedmethod SePre uses only antigen sequence
information. It recommends conformational B-cell epi-
topes by applying the distance-based clustering algorithm
on a structure that is predicted from the given antigen
sequence. Thus, it is suitable for large-scale predictions
and has much broader applications, such as the discovery
of new epitopes and their corresponding antibodies, and
the investigation of new antigens of a pathogen.
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Methods
Figure 2 illustrates the training (learning) and testing (pre-
diction) processes of the proposedmethod. The first-stage
and second-stage staged heterogeneity learning models
are trained on two data sets with heterogenous annota-
tions. For testing, these two models are used to predict
antigenic residues, and then an unsupervised cluster-
ing algorithm is deployed to cluster predicted antigenic
residues into conformational B-cell epitopes. This section
presents details of the heterogeneity learning method, the
clustering algorithm for recommending conformational
epitopes, and in-house baseline algorithms for perfor-
mance comparison, as well as the data sets and propensi-
ties used.
Staged heterogeneity learning
The staged heterogenous learning method has two stages
of learning (refer to the upper part of Fig. 2). In the
first stage, the method learns the general epitope pat-
terns of each type of propensity from a large training
data set. For each type of propensity, a sub-classifier is
constructed. In the second stage, the method focuses on
learning the complementarity of the propensities from a
small heterogeneous training data set, taken as guided
data. To prepare the training input data for the second
stage (shown by dotted arrows), predictions are made by
the sub-classifiers on the guided heterogeneous data set.
The probabilities predicted by each sub-classifier are used
to train the second-stage model. As to the machine learn-
ing strategy, random forest is used to train the first-stage
sub-classifiers, and decision tree is applied in the second
stage.
The lower part of Fig. 2 represents how the proposed
method makes predictions. The testing data is firstly pre-
dicted by the first-stage sub-classifiers, and the probabili-
ties of the residues belonging to epitopes are generated by
each of the sub-classifiers. Then, the second-stage model
integrates these probabilities to predict antigenic residues.
The epitope patterns are diversified and relatively com-
plicated to learn, and hence more data is needed for
the first-stage learning. However, the second-stage model
only needs to deal with a few probability values. A simple
learning algorithm and a relative small amount of guided
data can be qualified to get good prediction performance.
Clustering antigenic residues into conformational B-cell
epitopes
The staged heterogeneity learning method presented in
“Staged heterogeneity learning” section only predicts
whether or not a residue is antigenic. It does not distin-
guish which antigenic residues can be grouped to con-
stitute a conformational B-cell epitope. We propose a
clustering method (Algorithm 1) to group the neighbor-
ing individual residues into clusters, and recognize each
cluster as a conformational B-cell epitope. The aggregated
antigenic residues are then recommended with higher
Fig. 2 Training and testing processes of the proposed method. The upper part illustrates the training process. The first-stage and second-stage
staged heterogeneity learning models are trained on two data sets with heterogenous annotations. The lower part illustrates the testing process of
the proposed method. An unsupervised clustering algorithm is involved in the testing process to recommend conformational B-cell epitopes. The
shapes inside data sets denote patterns of propensities: PC–physico-chemical propensity, ASA–accessible surface area, SS–secondary structure,
PSSM–position-specific scoring matrix
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priority based on the idea that aggregative antigenic
residues are more likely to constitute epitopes [21].
Algorithm1Making recommendations of conformational
B-cell epitopes from an antigen sequence
1: Input:
2: (1) An antigen sequence agseq
3: (2) Predicted antigenic residues agresidue
4: Step1: Search or predict an antigen structure from
agseq.
5: Step2: Form conformational epitopes.
6: Initialization:
7: Candidate conformational epitope list celist = []
8: The first epitope ce1 = [a randomly selected anti-
genic residue r1]
9: Add ce1 into celist
10: Remaining antigenic residue listrlist = agresidue-
r1
11: while ce in celist do
12: Iteratively extend ce by adding a residue r in rlist, if
r is within dist distance from any residue in ce, and
remove r from rlist
13: if rlist == NULL then
14: Return celist
15: else
16: ce-new = [a randomly selected antigenic residue
in rlist]
17: Add ce-new into celist
18: end if
19: end while
The first step is to search or construct the correspond-
ing antigen structure from an antigen sequence. This
involves aligning the target antigen sequence with PDB
structures by BLAST. If there is a structure with 100%
sequence similarity, it is assigned as the structure of the
antigen. If no eligible structure is available, a structure is
constructed by I-TASSER [22]. The second step is to clus-
ter the predicted candidate antigenic residues according
to their distance information in the structure.
Data sets
Two types of epitope data sets, extracted from different
data sources, were used for the training and assess-
ment of the proposed method: (i) computational epi-
topes derived from antigen-antibody bound structures
in PDB, and (ii) experimentally determined epitopes by
various types of assay from IEDB [23]. Two data sets
were used in the training: a computational epitope data
set named ‘Train190’ was used for training the first-
stage model; a small experimental epitope data set named
‘Liang19unbound’ was used as the guided data for train-
ing the second-stagemodel. Three test data sets were used
to assess the method’s prediction performance: ‘Exp104’
and ‘Exp163’ contain experimentally determined epitopes,
and the third, ‘Ren92unbound’, contains computational
defined epitopes.
In this work, a residue is computationally defined as
an epitope residue if it has a non-hydrogen atom within
5Å distance from any antibody atom, and loses more than
0.6Å2 of its exposed area upon binding.
Details of the two training data sets
‘Train190’ consists of 190 bound structures with 195 non-
redundant antigen chains. The epitope annotations were
calculated from the antigen-antibody bound structures in
PDB. This data set was used for learning the complicated
epitope patterns of each kind of propensity in the first
stage. It was constructed using the following steps. Firstly,
we computationally defined epitopes from 598 antigen-
antibody bound structures [6]. Then, the antigen chains
were grouped into 217 clusters using CD-HIT [24] with
a sequence similarity threshold of 70% (-c 0.7). Next, the
epitopes within each cluster were mapped onto a repre-
sentative chain. In the last step, we removed epitopes that
could not be completely aligned with the representative
chain and representatives without any epitopes.
‘Liang19unbound’ contains 19 antigen unbound struc-
tures. Their epitopes were annotated using IEDB [13].
This data set was used as the guided data to learn the
complementarity of propensities in the second stage.
Details of the three test data sets
‘Exp104’ contains 104 bound structures with experimen-
tally determined epitopes from IEDB. It was constructed
via these steps: (i) extract experimentally determined con-
formational epitopes from IEDB; (ii) retrieve their source
antigen sequences through GeneBank ID, and their corre-
sponding structures through UniProt ID; and (iii) map the
epitopes onto these structures.
‘Exp163’ consists of 163 unbound structures whose
annotations also came from the experimentally deter-
mined epitopes in IEDB. It was used as another test set
to assess performance on heterogeneous data with more
unbalanced labels.
‘Ren92unbound’ has 92 unbound structures with com-
putational B-cell epitopes [6], and was used to assess the
performance of the staged heterogeneity learning method
in computational epitopes, as well as the impact of the
second-stage heterogeneity learning on the prediction
performance in homologous computational epitopes.
Propensities
Previous studies have shown that epitope residues have a
preference on certain propensities. In PUPre [6], we found
that even different species demonstrate similar, though
not identical, tendencies in propensities such as ASA,
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RSA, protrusion index and B-factor. Therefore, learning
the epitope preferences of propensities is both useful and
necessary to heterogeneity learning.
Many propensities are believed to be able to help dis-
tinguish epitope residues from non-epitope residues, and
have been widely applied in the analysis and prediction
of conformational B-cell epitopes, including hydrophilic-
ity [25], amino acid composition [1, 14], conservation
score [14, 26], PSSM [17, 19], secondary structure [13],
surface exposure propensities [8, 9, 15, 21], contact num-
ber [1, 13], and protrusion index [4].
In this paper, we assessed five types of sequence-derived
propensities, including: 205 physico-chemical propensi-
ties extracted from AAindex [27] with less than 80%
similarity, evolutionary propensities–PSSM and conser-
vation score, and predicted structural propensities–ASA
and secondary structure. Among them, the physico-
chemical propensities were directly extracted from anti-
gen sequences; the PSSM profile and conservation score
were generated by PSI-BLAST and ConSurf [28] respec-
tively. The ASA and secondary structure were predicted
by SABLE [29]. We found that the conservation score
always gave poor performance on epitope identification
and sometimes was not available. This is further discussed
in “The first-stage performance by single propensities”
section. Therefore, it was excluded from the construction
of the learning model. To account for the impact of sur-
rounding residues, a seven-residue sliding window was
applied to the construction of feature space.
Baseline algorithms
We applied several baseline algorithms to examine the
complementarity of the propensities, including ranked
voting, exhaustive voting, and traditional machine learn-
ing methods (including SVM, random forest, regression
tree, Naïve Bayesian, and Bayesian network). These tra-
ditional machine learning methods were implemented by
R packages with parameter optimization. Here, we briefly
describe the ranked and exhaustive voting algorithms.
Algorithm 2 Ranked voting algorithm
1: Input: ranklist = ranked propensities (high to low
performance)
2: Initialization: candidate voting propensities votelist =
NULL
3: while propensity pi in ranklist do
4: Voting step: vote by propensities in [votelist, pi]
5: if F-score improves then




Using the ranked voting algorithm (Algorithm 2),
propensities are firstly ranked by their performance in
identifying conformational B-cell epitopes, and then the
selected propensities vote to decide the label of a residue.
A residue is predicted as positive if the number of positive
votes are greater than or equal to the negative votes (con-
dition 1), and it has at least one positive vote (condition
2). The second condition handles rare situations in which
none of the propensities has a positive value. In this case,
a negative (silent) prediction is assigned.
Simple combinations of top-ranked propensities do not
necessarily guarantee the best prediction performance [1].
Hence, an exhaustive voting algorithm was designed and
conducted on all the possible combinations of propensi-
ties. Given the original 209 propensities would produce
2209−1 combinations, leading to very high complexity for
exhaustive voting, we firstly combined the 205 physico-
chemical propensities from AAIndex to construct one
sub-classifier, and then conducted exhaustive voting on
the five groups of propensities.
Results
This section presents the outstanding epitope prediction
performance by our staged heterogeneity learningmethod
in comparison with state-of-the-art methods. Two case
studies are also presented to illustrate the prediction
details of the heterogeneity learning method.
Superior performance by staged heterogeneity learning
Our staged heterogeneity learning method, SePre, was
tested on both heterogeneous (‘Exp104’ and ‘Exp163’)
and homologous (‘Ren92unbound’) data sets. To bench-
mark the performance, our method was compared with
CBTOPE, a sequence-based conformational B-cell epi-
tope predictor [16]. We attempted to compare with other
sequence-based prediction methods [17, 18, 20], but their
server or software package was not available. We also
compared SePre with three typical structure-based pre-
dictors: DiscoTope 2.0 [15], ElliPro [4] and SEPPA 2.0 [7].
Their servers provided batch query entries - convenient
for large-scale comparison.
The prediction results are summarized in Table 1. On
all of the test data sets, SePre had the best F-scores
and the best precisions. The best recalls were achieved
by ElliPro, but it had a much lower precisions. Overall,
SePre achieved significantly better performance than the
state-of-the-art methods.
On the two heterogeneous data sets, the comparing
methods demonstrated very low performance: very low
precisions in particular. This is probably because the epi-
topes of the two test data sets are quite different from
those of the training data sets. Our prediction perfor-
mance was as expected, as our method is a heterogeneity-
focused learning method. Against ‘Exp104’, SePre had a
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Table 1 Prediction performance by staged heterogeneity
learning in comparison with other prediction methods
Predictor Dataset Recall Precision F-score
SePre Exp104 0.454 0.234 0.308
CBTOPE Exp104 0.516 0.051 0.092
DiscoTope 2.0 Exp104 0.230 0.066 0.102
ElliPro Exp104 0.705 0.066 0.121
SEPPA 2.0 Exp104 0.524 0.096 0.163
SePre Exp163 0.314 0.159 0.211
CBTOPE Exp163 0.492 0.052 0.094
DiscoTope 2.0 Exp163 0.231 0.051 0.083
ElliPro Exp163 0.686 0.047 0.089
SEPPA 2.0 Exp163 0.429 0.063 0.110
SePre Ren92unbound 0.639 0.426 0.511
CBTOPE Ren92unbound 0.544 0.133 0.213
DiscoTope 2.0 Ren92unbound 0.279 0.162 0.205
ElliPro Ren92unbound 0.702 0.120 0.205
SEPPA 2.0 Ren92unbound 0.484 0.164 0.245
The boldface data highlights the optimal performance
much higher precision, at 0.234, and achieved a much
higher F-score, at 0.308. For a close comparison, although
CBTOPE had a slightly higher recall, its F-score was only
0.092. SEPPA 2.0 used antigen structure information in
this bound data set and showed the best performance
among the three structure-based predictors, but its F-
score was only 0.163. On ‘Exp163’, an unbound and more
unbalanced data set, SePre still showed a good perfor-
mance: its F-score was 0.211 with a recall of 0.314 and
a precision of 0.159 - nearly twice the performance of
the next best predictor, SEPPA 2.0, with an F-score of
0.110. On the homologous data set ‘Ren92unbound’, SePre
achieved an excellent F-score of 0.511, while the best F-
score of the other predictors was only 0.245, again by
SEPPA 2.0. These results imply that our heterogeneity
learning method is quite compatible with homologous
data as well.
Prediction results by straightforward staged learning
In conventional practice, a training process is usually con-
ducted on a single homologous data set. To examine
the improvement made by staged heterogeneity learn-
ing, a straightforward staged learning model (denoted by
SePre.v0) was also constructed. It has a similar process as
SePre, except that its second-stage model is trained on the
homologous data from ‘Train190’, and its training input
is generated from the LOOCV results of the first-stage
model.
Table 2 shows the prediction results using a straightfor-
ward staged learning model. The performance of SePre.v0
Table 2 Prediction results by straightforward staged learning
Predictor Dataset Recall Precision F-score
SePre.v0 Exp104 0.793 0.085 0.153
SePre.v0 Exp163 0.744 0.055 0.102
SePre.v0 Ren92unbound 0.923 0.186 0.310
SePre.v0 in this table is different from the proposed SePre model. Its second-stage
model was trained on the leave-one-out cross-validation (LOOCV) results from the
first-stage model. In LOOCV, if an antigen has multiple chains, these chains are all
left out as tests in a round to reduce the coupling between a target antigen and the
training data
wasmuch lower, compared to SePre. On the two heteroge-
neous data sets, its precision was also much lower, leading
to a considerable decline in F-scores: from 0.308 to 0.153
on ‘Exp104’, and from 0.211 down to 0.102 on ‘Exp163’.
Though their recalls improved to 0.793 and 0.744 respec-
tively, these results mean that the predictor has predicted
most of the antigen sequences as antigenic residues. Even
on the homologous data set ‘Ren92unbound’, SePre.v0 suf-
fered from a decrease in F-scores - from 0.511 to 0.310.
Over-fitting in the second-stage of training is a possible
explanation.
Results on recommending conformational B-cell epitopes
SePre only makes predictions on whether a residue of
an antigen sequence is an antigenic residue. Algorithm 1
can cluster these individual antigenic residues into groups,
and identify each of the groups as a candidate for a confor-
mational B-cell epitope. The algorithm was evaluated on
the three test data sets.
The algorithm’s dist parameter was set to range from
2Å to 18Å. The prediction results are summarized in
Table 3. Previous literature has reported that the total
number of residues per epitope ranges from about 10
to 20 [5], and we chose the distance 6 Å as the default
distance threshold (dist) of this clustering algorithm.
Aggregated antigenic residues are more likely to con-
stitute epitopes [21]. Based on this idea, we ranked the
epitope candidates according to their number of residues.
Figure 3 illustrates the change in performance when the
recommendation level changed. After removing those
isolated antigenic residues, SePre demonstrated further
improvement, providing more useful and meaningful rec-
ommendations. On ‘Exp104’, the best F-score was 0.325
(dist = 4Å and MinResidue = 9); On ‘Exp163’, the best F-
score was 0.235 (dist = 6Å and MinResidue = 9); and on
‘Ren92unbound’, the best F-score is 0.527 (dist = 6Å and
MinResidue = 6). These results suggest that the algorithm’s
default parameters should be 6Å for dist and 9 residues for
MinResidue.
SePre uses the distance-based clustering algorithm with
only antigen information to recommend conformational
B-cell epitopes. Thus, it is unlikely to accurately locate
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Table 3 Statistical summary of the recommended conformational B-cell epitopes
Distance N(cluster) Maxlen Minlen Avelen N(cluster) Maxlen Minlen Avelen N(cluster) Maxlen Minlen Avelen
4 3.94 18.78 4.13 8.68 5.49 11.30 2.38 4.66 5.47 22.95 4.55 9.23
6 2.83 20.99 8.50 12.90 4.44 12.82 4.11 6.79 3.87 26.45 9.28 14.28
8 2.28 22.06 13.10 16.21 3.45 14.73 6.83 9.58 2.73 28.77 14.57 20.01
10 2.00 22.49 14.12 17.27 2.88 15.71 8.02 10.83 2.33 29.84 16.93 21.86
12 1.81 22.77 15.23 18.42 2.47 16.50 9.80 12.36 1.88 31.11 21.97 25.67
14 1.63 23.02 16.60 19.45 2.12 17.23 11.35 13.56 1.62 31.62 23.93 27.22
16 1.48 23.55 18.57 20.87 1.79 18.13 13.26 15.27 1.46 32.07 26.42 28.96
18 1.36 23.65 20.16 21.76 1.61 18.56 15.60 16.79 1.35 32.34 28.49 30.27
Three sets of results from the three test data sets (from left to right): ‘Ren92unbound’, ‘Exp106’ and ‘Exp165’. Each group includes columns of N(cluster), Maxlen, Minlen and
Avelen. N(cluster) stands for the average number of epitopes on each antigen, Maxlen is the maximum length of residues of an epitope, and Minlen is the minimum length of
residues of an epitope, Avelen indicates the average length of residues of an epitope
each epitope to a specific antibody; especially, it cannot
distinguish overlapped epitopes.
Case studies
We present detailed prediction results on two case stud-
ies. The first case study was conducted on a glucose-
dependent insulinotropic polypeptide receptor. It has a far
kinship from any of the training sequences. The highest
sequence similarity to the antigen chains in ‘Train190’ is
only 19.5%, and only 9.6% to the ‘Liang19unbound’ data
set. The epitope site of this antigen has been confirmed
previously by several types of experimental methods, such
as biological activity neutralization, surface plasmon reso-
nance (SPR) dissociation and x-ray crystallography (IEDB
Epitope ID: 194683).
SePre’s precision was the highest (0.667) for this epitope
prediction in comparison to the other prediction methods
(Fig. 4). SePre predicted six residues as antigenic residues:
four of them (red spheres in Fig. 4a) were true anti-
genic residues, and the remaining two were incorrectly
identified as epitope residues (yellow sticks). By compar-
ison, the straightforward model correctly identified nine
of the 17 antigenic residues from amongst its total of 55
predicted antigenic residues. Its precision was only 0.164,
much lower than ours.
The sequence-based method, CBTOPE, had a slightly
lower F-score (0.320 compared to our 0.348). It correctly
identified eight antigenic residues within its 33 positive
predictions, and had a precision of 0.242. SePre also
outperformed the three structure-based predictors. The
predicted antigenic residues by ElliPro and SEPPA 2.0 dis-
persed substantially over the surface with a precision of
only 0.210 and 0.111 respectively. DiscoTope 2.0 had the
same recall with SePre, however, its precision was worse
(0.444 compared to SePre’s 0.667).
The predicted antigenic residues were clustered into
two conformational epitopes by Algorithm 1: one con-
tained five nearby antigenic residues, and the other had
only one antigenic residue (residue 101 in chain A). The
larger one was recommended with a higher priority. The
Fig. 3 Performance by the recommendation algorithm under different parameters. (a) Ren92unbound, (b) Exp104, (c) Exp163. The y-axis shows the
F-score. MinResidue refers to the minimum residues included in a recommended conformational epitope
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Fig. 4 Prediction on a glucose-dependent insulinotropic polypeptide receptor (PDB ID: 2QKH, chain: A). (a) SePre, (b) Straightforward model, (c)
CBTOPE, (d) DiscoTope 2.0, (e) ElliPro, (f) SEPPA 2.0. The epitope (IEDB epitope ID: 194683) is shown as spheres: the correctly predicted epitope
residues (true positive) are colored in red, while the unrecognized epitope residues (false negative) are colored in orange. The non-epitope residues
predicted as epitope (false positive) are shown as yellow sticks
recommended five-residue conformational epitope con-
sisted of nearby antigenic residues with only one false
positive prediction. The precision was further improved
to reach 0.80.
The second case study was conducted on an N9 neu-
raminidase of the influenza A virus (PDB ID: 1NCA,
chain: A).
Eight epitopes determined by various determination
assays (IEDB ID: 77480-77483,77486-77489) can be
mapped onto this antigen. These epitopes overlap, con-
taining a total of 33 unique antigenic residues (Fig. 5).
SePre’s F-score was 0.650 with a recall of 0.788 and
an excellent precision of 0.553. That is, of the 47 pre-
dicted antigenic residues, 26 are true antigenic residues.
The straightforward model identified 28 true antigenic
residues, with an improved recall of 0.848. Nevertheless, it
made a total of 143 positive predictions. Its precision was
only at a low level of 0.196, leading to an F-score of 0.318.
This F-score was much lower than SePre’s 0.650.
The best performance of the other methods was made
by DiscoTope 2.0 which had an F-score of 0.464. Dis-
coTope 2.0 also correctly identified 26 true antigenic
residues (recall = 0.788), but its total of 53 false posi-
tive predictions was far greater than SePre’s total of 21,
and thus its precision was only 0.329. The F-scores of
CBTOPE, ElliPro, and SEPPA 2.0 were 0.292, 0.217 and
0.416, respectively.
Though our clustering algorithm, the predicted anti-
genic residues were grouped into three candidates for con-
formational epitopes (Fig. 5(f)). The first one (shown as
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Fig. 5 Prediction on an influenza A N9 neuraminidase antigen (PDB ID: 1NCA, chain: A). (a) Epitopes, (b) SePre, (c) Straightforward model
(d) CBTOPE, (e) DiscoTope 2.0, (f) ElliPro, (g) SEPPA 2.0, (h) Conformational epitopes. The spheres represents the annotated epitope residues in
a–g, and in h they represent the predicted epitope residues. The color mode for b–g are the same as Fig. 4. In h, three clusters are formed by
Algorithm 1 and colored in red andmagenta, orange and yellow. The largest cluster colored in red (annotated epitope residues) andmagenta (other
residues) is recommended with priority
red and magenta spheres) contains 42 antigenic residues,
and the other two contain three (orange) and one (yellow)
residues respectively. The largest one was preferentially
recommended as a conformational epitope. As five false
positive predictions (including the two small clusters and
a buried residue) were removed from the recommenda-
tion and the 26 true predictions of antigenic residues
were kept in the cluster. The prediction performance was
further improved by the clustering algorithm.
Discussion: where performance improvements are
made in the staged heterogeneity learningmodel
This section presents the prediction performance by sin-
gle propensities in the first stage, and describes how
the performance is improved when the second stage is
added. There are three important factors which can con-
tribute to the excellence of the prediction performance:
(i) choosing a good learning method on single propensi-
ties, (ii) choosing a good second stage learning method,
and (iii) heterogenous learning (results already presented
in “Prediction results by straightforward staged learning”
section).
The first-stage performance by single propensities
Propensities have been intensively used for epitope iden-
tification [1, 3, 25]. Epitopes also have strong preferences
on certain propensities even for diversified antigens from
different species [6]. In the first stage of our learning
method, each propensity makes independent decisions
on the probability of a residue being antigenic. Here, we
describe the performance demonstrated by the various
single propensities through LOOCV.
Table 4 summarises prediction performance by single
propensity. The predictions were made using a random
forest model and an SVM model under a LOOCV pro-
cess on ‘Train190’. The 205 physico-chemical propensi-
ties were assessed separately (P1-P205). It can be seen
that the sequence-predicted structural propensities ASA
(P206) and secondary structure (P208), and the evolu-
tionary propensity PSSM (P209) had a stable top-ranked
predictive capability. By comparison, the static physico-
chemical propensity based predictions varied greatly in
their performance, especially in the SVM model. Another
evolutionary propensity, conservation score (P207), had
poor predictive power in both the random forest and
SVM models. It is consistent with our previous results
on the influenza hemagglutinin [26]: conservation score
has a poor performance in identifying antigenic residues.
Additionally, 85 antigens in ‘Train190’ have no con-
servation score information. This presents a significant
obstacle for the conservation score based method. Given
its poor performance and in-availability, conservation
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Table 4 Prediction performance of single propensities by LOOCV using Random Forest (column 2–5) and SVM (column 6–9)
Rank Propensity Recall Precision F-score Propensity Recall Precision F-score
Best1 P209 0.618 0.188 0.289 P206 0.720 0.177 0.284
Best2 P206 0.646 0.174 0.274 P209 0.630 0.179 0.279
Best3 P170 0.560 0.173 0.265 P208 0.724 0.167 0.271
Worst3 P122 0.362 0.165 0.227 P84 0.061 0.215 0.095
Worst2 P46 0.341 0.170 0.227 P166 0.090 0.100 0.095
Worst1 P44 0.283 0.169 0.212 P142 0.084 0.090 0.087
Average 0.537 0.165 0.252 0.407 0.163 0.219
The propensity 208 (secondary structure) ranks fourth in RF, and has a recall of 0.670, precision of 0.164, and F-score of 0.264. Propensity 207 (conservation score) ranks 201
and 100 in RF and SVM, and has an F-score of 0.239 and 0.235 respectively. Explanations to other important propensities: 209-PSSM, 206-ASA, 170-Optimized
beta-structure-coil equilibrium constant (AAIndex ID: OOBM850101). AAIndex ID for worst propensities: 122-CHAM830107, 46-FAUJ880111, 44-FAUJ880112, 84-AURR980110,
166-OOBM770104, 142-GEOR030104. Antigens without a certain propensity were ignored in this table
score was excluded from the construction of our learn-
ing method. Considering the average F-score on all the
209 propensities, the performance of the random for-
est model (0.252) was superior to SVM (0.219). There-
fore, we selected the random forest approach, with the
mtry parameter set as the window size, to train the sub-
classifiers.
From Table 4, we can observe that more powerful
propensities generally have a remarkably higher recall,
and a slightly higher precision than the less informa-
tive propensities. This suggests that epitope does have a
strong preference on these propensities, and that a single
propensity is not sufficient to accurately identify antigenic
residues.
To reduce the potential impact of a few long antigen
sequences on overall performance, an additional analysis
was conducted by computing the average F-score on each
complex. ASA and secondary structures were ranked as
the top two propensities in both random forest and SVM
methods, and achieved an average F-score of more than
0.395. PSSM had an average F-score of 0.378 (RF) and
0.362 (SVM), while the conservation score had an average
F-score of 0.283 (RF) and 0.268 (SVM), respectively.
Why need the second stage to learn the intrinsic
complementarity of propensities and which learning
method is appropriate
Since various propensities contribute to binding affinity,
the collective synergy of the propensities should be incor-
porated in any prediction model. Existing studies have
investigated several ways to integrate the propensity com-
plementarity, like linear combination [17], re-sampling
and voting [20], or data mining methods [19].
Here, we compare the performance of several propen-
sity integration methods, including simple voting meth-
ods methods (ranked and exhaustive), data mining
methods (SVM and random forest), Bayesian meth-
ods (Naïve Bayesian and Bayesian network) and tree
algorithms (decision tree and regression tree). These
experiments were performed on the data derived from
the first-stage prediction probabilities by LOOCV on the
training data set ‘Train190’. A dummy value or vote was
assigned when a propensity value was not available. The
performance results are listed in Table 5.
The ranked voting algorithm was carried out on all the
209 propensities. Voting on the three propensities PSSM,
ASA and the optimized beta-structure-coil equilibrium
constant achieved optimal performance: the best F-score
was 0.295, and the recall and precision were 0.650 and
0.191 respectively. The exhaustive voting algorithm was
performed on the five groups of propensities, and the best
Table 5 Performance by various propensity integration methods
Group Methods Propensities Recall Precision Fscore
Voting Ranked votinga 209 0.650 0.191 0.295
Exhaustive voting 5 groups 0.656 0.191 0.295
General SVM 5 groups 0.614 0.181 0.279
Random forest 5 groups 0.600 0.186 0.284
Bayesian Naïve Bayesian 5 groups 0.686 0.193 0.301
Bayesian network 5 groups 0.775 0.173 0.283
Tree Decision tree 5 groups 0.675 0.196 0.304
Regression tree 5 groups 0.655 0.194 0.299
General SVM 209 0.594 0.191 0.289
Random forest 209 0.639 0.191 0.294
Bayesian Naïve Bayesian 209 0.633 0.198 0.301
Bayesian network 209 0.586 0.170 0.264
Tree Decision tree 209 0.633 0.198 0.301
The parameters used in these models are tuned to realize an optimal performance.
The best ranked voting was achieved by propensity PSSM (P209), ASA (P206) and
optimized beta-structure-coil equilibrium constant (P170, AAIndex ID: OOBM850101).
The best exhaustive voting results was realized by a combination of PSSM, physico-
chemical propensities and ASA
aDue to the complexity of exhaustive voting algorithm, only five groups of propensities
were used. Regression tree constructed on 209 propensities required too much
computation time, and no results were obtained
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performance was achieved by a combination of PSSM,
ASA and all the physico-chemical propensities. The best
F-score was also 0.295, while the recall (0.656) was slightly
better than the ranked voting algorithm (0.650), indi-
cating that the incorporation of the other 204 physico-
chemical propensities has little contribution to the overall
performance.
For the data mining methods with five groups of
propensities, SVM and random forest did not improve
prediction performance over single propensity based sub-
classifiers, even after parameter optimizations. The best
F-score was only 0.284 (by random forest), which was
not better than only using a PSSM profile (0.289). Yao
et al. mentioned that sophisticated data mining methods
are more suitable for larger numbers of propensities [30].
These data mining methods were thus further applied
to all the 209 propensities, to fully exploit the potential
of these data mining algorithms. As shown in the bot-
tom rows of table, these data mining methods achieved
improved performance over the five-propensity counter-
parts with a better F-score of 0.294 (random forest model).
By comparison, simpler data mining methods, such as
decision tree and Naïve Bayesian, seemed to yield better
performance with both higher recall and greater preci-
sion. The decision tree algorithm, based on five groups of
propensities, performed best with an F-score of 0.304, a
recall of 0.675 and a precision of 0.196.
The reason for the varied results of different propensity
integration methods is possibly attributed to the nature
of the problem. The collective synergy of propensities
in epitopes should not be a complicated problem, but
heterogeneity exists among samples. Voting algorithms
oversimplify the problem, and fail to consider the differ-
ent contributions of propensities in epitope identification.
Advanced data mining methods, such as SVM and ran-
dom forest, overfit the training data, and achieve very
little improvement on heterogeneous samples. The sim-
ple data mining methods, like decision tree and Naïve
Bayesian, however, make a tradeoff between complexity
and overfitting, which provides a tremendous value to
quality heterogeneity learning.
Conclusions
In this paper, we proposed a staged heterogeneity
learning algorithm to deal with the high complexity
of heterogeneity in antibody-antigen interactions for
accurate conformational B-cell epitope prediction. The
prediction model first learns the complicated epitope
patterns of each type of propensities, and then learns the
complementarity of propensities on a small guided het-
erogeneous data set. With only sequence information, our
proposed model outperformed the state-of-the-art
sequence-based and structure-based prediction methods
on both heterogeneous and homologous data sets.
We also investigated how these dramatic performance
improvements were made, by assessing the performance
of a straightforward staged learning model, single-
propensity based sub-classifiers, and various propensity
integration methods. A clustering algorithm was also
designed to make recommendations for conformational
B-cell epitopes from the predicted antigenic residues to
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